Top news of the week: 25.08.2020.
#biotechnology #lifesciences #COVID19 #microbiome #summer #biotech #COVID #treatment #geneediting #vaccine
Career And Jobs
Here are 7 #biotech #books for the #summer that will take you from #CRISPR #geneediting to the #microbiome to pharma and economics, as well as sci-fi that takes biotech to space! What's your reading list for this summer? 🌞📚
https://t.co/tSjeQooasQ
Open7 Biotech Books to Read in the Sun this Summer
Here are seven biotech books for the summer that will take you from CRISPR gene editing to the microbiome to pharma and economics, as well as sci-fi that takes biotech to space. The ...
Biopharma Update on the Novel Coronavirus: August 24
#biospace #lifesciences #biotechnology #pharmaceuticals
#COVID-19 #coronavirus #pandemic #COVID19 #treatment #vaccine
https://t.co/WnpMs0B4jq
OpenBiopharma Update on the Novel Coronavirus: August 24
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for August 24, 2020.
MassBio is proud to announce that Abbie Celniker, Ph.D., Partner at @ThirdRockV, will receive the Henri A. Termeer Innovative Leadership Award during the #StateofPossible Conference on 8/26. To learn more about Abbie's influence & accomplishments, visit: https://t.co/R5oIWgr9F5 https://t.co/98qKfWBxsJ
OpenMassBio® to Honor Abbie Celniker with Henri A. Termeer Innovative Leadership Award
MassBio today announced that Abbie Celniker, Ph.D., Partner at Third Rock Ventures, will receive the Henri A. Termeer Innovative Leadership Award during its 2020 State of Possible ...
From Ebola in Africa to #biotechnology in Washington DC — with @Michelle_Rozo
She’s worked across continents, industries, and the government to use the #lifesciences to improve people’s lives. https://t.co/DZ0G2K0pDk @1AlexanderTitus
OpenFrom Ebola in Africa to biotechnology in Washington DC — with Michelle Rozo
She’s worked across continents, industries, and the government to use the life sciences to improve people’s lives.
The Endpoints 11 celebrates biopharma's most promising startups. Live event on September 30
https://t.co/t3nwuKfryg
OpenThe Endpoints 11 celebrates biopharma's most promising startups. Live event on September 30
Next month John Carroll and the Endpoints editorial team continue a proud tradition of profiling a standout group of 11 startups that just might be headed for greatness. And we're adding a ...
Aslan hopes to roar again as Dupixent rival test resumes after COVID-19 chaos https://t.co/iS6rRrw1oM https://t.co/FdmBGpoGm6
OpenAslan hopes to roar again as Dupixent rival test resumes after COVID-19 chaos
Singapore-based Aslan Pharmaceuticals is hitting go again on its stalled dermatitis study.
Driving to the $278M mark on raises, a legendary R&D expert sets his sights on another pivotal goal line
(And then what?)
https://t.co/ifBkhtYUa4
OpenDriving to the $278M mark on raises, a legendary R&D expert sets his sights on another pivotal goal line
Thinking back on his arrival at a fledgling Kronos Bio a little more than 2 years ago, Norbert Bischofberger — otherwise known as employee #5 — was acutely aware of the work that needed to ...
Ingenza meets a key milestone in the deployment of novel cost-effective COVID-19 vaccine technology
https://t.co/gjMrjIocTy
#news #pharma #pharmiweb
OpenIngenza meets a key milestone in the deployment of novel cost-effective COVID-19 vaccine technology
Edinburgh-based biotech company Ingenza Ltd. has made a significant breakthrough in the race to develop and manufacture a cost-effective vaccine against SARS-CoV-2, the virus responsible ...